
Back
EGFR-mutated mNSCLC: Updates from WCLC 2025
Experts discuss key WCLC updates in the diagnosis and treatment of EGFR-mutated NSCLC. The conversation highlights patient burden with frontline combination regimens and reviews pivotal data from the MARIPOSA and FLAURA2 trials.
Advertisement
Advertisement
Trending on OncLive
1
FDA Removes Limitations of Use for Liso-Cel in Primary Central Nervous System Lymphoma
2
Sintilimab Receives Positive CHMP Opinion for First-Line Nonsquamous NSCLC
3
Galinpepimut-S Improves OS in AML in Second or Later Remission
4
ESMO 2026 Data Highlight ADC Activity in Brain Metastases and TNBC
5
